COMPARATIVE EFFECTIVENESS OF VEDOLIZUMAB AND USTEKINUMAB IN ANTI-TNF REFRACTORY CROHN'S DISEASE: MULTI-CENTRE RETROSPECTIVE COHORT STUDY

被引：1
|
作者：
Townsend, Tristan [1 ]
Razanskaite, Violeta [2 ]
Michail, Stephanie [1 ]
Morgan, James [1 ]
Davies, Michael [1 ]
Storey, Daniel [1 ]
Watters, Christopher [3 ]
Penman, Douglas [3 ]
Swaminathan, Mira [4 ]
Reilly, Ian [4 ]
Flanagan, Paul
Subramanian, Sreedhar [1 ]
机构：
[1] Royal Liverpool Univ Hosp, Liverpool, Merseyside, England
[2] Aintree Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England
[3] Arrowe Pk Hosp, Upton, England
[4] Countess Chester Hosp, Chester, Cheshire, England
来源：
GUT | 2021年 / 70卷
关键词：
D O I：
10.1136/gutjnl-2020-bsgcampus.237
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P162
引用
收藏
页码：A127 / A127
页数：1
相关论文
共 50 条
  • [41] Single Center Experience With Long-term Ustekinumab in Patients With Refractory Crohn's Disease (Prior Anti-TNF and Vedolizumab Therapy)
    Bennett, Audrey L.
    Evers, Lauren
    Duley, Caroline V.
    Annis, Kim
    Beaulieu, Dawn B.
    Adams, Dawn W.
    Schwartz, David A.
    Horst, Sara N.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S397 - S398
  • [42] USTEKINUMAB IS ASSOCIATED WITH BETTER EFFECTIVENESS OUTCOMES WHEN COMPARED TO VEDOLIZUMAB IN CROHN'S DISEASE PATIENTS WITH PRIOR FAILURE TO ANTI-TNF: A COMPARATIVE EFFECTIVENESS STUDY FROM THE DUTCH ICC REGISTRY
    Biemans, Vince
    Van der Woude, Christien Janneke
    Dijkstra, Gerard
    Meulen-de Jong, Andrea V.
    Lowenberg, Mark
    de Boer, Nanne
    Oldenburg, Bas
    Srivastava, Nidhi
    Jansen, Jeroen M.
    Bodelier, Alexander
    West, Rachel
    de Vries, Annemarie C.
    Haans, Jeoffrey
    De Jong, Dirk J.
    Hoentjen, Frank
    Pierik, Marie
    GASTROENTEROLOGY, 2020, 158 (06) : S207 - S208
  • [43] Ustekinumab Efficacy and Safety in Crohn's Disease Patients Refractory to Conventional and Anti-TNF Therapy: A Multicenter Retrospective Experience
    Wils, Pauline
    Bouhnik, Yoram
    Flourie, Bernard
    Brixi, Hedia
    Cosnes, Jacques
    Allez, Matthieu
    Bernard, Duclos
    Michetti, Pierre F.
    Grimaud, Jean-charles
    Bommelaer, Gilles
    Amiot, Aurelien
    Fumery, Mathurin
    Jerome, Filippi
    Abitbol, Vered
    Coffin, Benoit
    Simon, Marion
    Laharie, David
    Pariente, Benjamin
    GASTROENTEROLOGY, 2015, 148 (04) : S115 - S116
  • [44] Report of successful use of ustekinumab in Crohn's disease refractory to three anti-TNF therapies
    Heetun, Z. S.
    Keegan, D.
    O'Donoghue, D.
    Doherty, G. A.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2014, 183 (03) : 507 - 508
  • [45] Effectiveness and safety of Ustekinumab for induction of remission in patients with Crohn's disease: a multi-centre Israeli study
    Shitrit, A. Bar-Gil
    Siterman, M.
    Waterman, M.
    Hirsh, A.
    Khoury, T.
    Schwartz, D.
    Zittan, E.
    Adler, J.
    Koslowsky, B.
    Avni-Biron, I.
    Chowers, Y.
    Ron, Y.
    Israeli, E.
    Ungar, B.
    Yanai, H.
    Maharshak, N.
    Ben-Horin, S.
    Ben-Ya'acov, A.
    Eliakim, R.
    Dotan, I.
    Goldin, E.
    Kopylov, U.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S399 - S400
  • [46] Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study(vol 22, 498, 2022)
    Rayer, Cassandra
    Nachury, Maria
    Bourreille, Arnaud
    Roblin, Xavier
    Peyrin-Biroulet, Laurent
    Viennot, Stephanie
    Flamant, Mathurin
    Laharie, David
    Caron, Benedicte
    Dewitte, Marie
    Siproudhis, Laurent
    Fumery, Mathurin
    Bouguen, Guillaume
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [47] Report of successful use of ustekinumab in Crohn’s disease refractory to three anti-TNF therapies
    Z. S. Heetun
    D. Keegan
    D. O’Donoghue
    G. A. Doherty
    Irish Journal of Medical Science (1971 -), 2014, 183 : 507 - 508
  • [48] Comparative effectiveness of vedolizumab and ustekinumab in Crohn's Disease patients who failed anti-TNF treatment: Interrogating 1019 patients from the UK IBD BioResource
    Desoki, R.
    Balendran, K.
    Kapizioni, C.
    Shawky, R.
    Parkes, M.
    Raine, T.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I118 - I118
  • [49] Effectiveness of swapping to ustekinumab after vedolizumab failure in patients with multi-refractory Crohn?s disease
    Melotti, Laura
    Dussias, Nikolas Konstantine
    Salice, Marco
    Calabrese, Carlo
    Baldoni, Monia
    Scaioli, Eleonora
    Belluzzi, Andrea
    Mazzotta, Elena
    Gionchetti, Paolo
    Rizzello, Fernando
    DIGESTIVE AND LIVER DISEASE, 2023, 55 (02) : 230 - 234
  • [50] Ustekinumab efficacy and safety in Crohn's disease patients refractory to conventional and anti-TNF therapy: a multicenter retrospective experience.
    Wils, P.
    Bouhnik, Y.
    Flourie, B.
    Brixi, H.
    Cosnes, J.
    Allez, M.
    Duclos, B.
    Michetti, P.
    Grimaud, J. -C.
    Bommelaer, G.
    Amiot, A.
    Fumery, M.
    Filippi, J.
    Abitbol, V.
    Coffin, B.
    Simon, M.
    Laharie, D.
    Pariente, B.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S37 - S39
12345